Statistical and Data Management Center (SDMC): Microbicide Trials Network
统计和数据管理中心 (SDMC):杀菌剂试验网络
基本信息
- 批准号:10175633
- 负责人:
- 金额:$ 347.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-29 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAddressAdolescentAffectBiological AssayBreast FeedingCOVID-19COVID-19 pandemicClinical DataClinical ManagementClinical TrialsClinical Trials DesignCodeCollectionDataData CollectionData Management ResourcesDatabasesDevelopmentEnsureEpidemicFacultyFundingGood Clinical PracticeGuidelinesHIVIndustry StandardInformation SystemsInternationalInterruptionLeadershipMethodologyMethodsMicrobicide Trials NetworkMonitorPractice ManagementPregnant WomenProceduresProcessProtocols documentationQuality ControlRecommendationRegulationReportingResearch DesignSafetySecureSpecimenStandardizationStatistical Data InterpretationStatistical MethodsSystemTMC120-R147681TestingTimeTrainingVaginal RingVulnerable PopulationsWomanWorkanti-HIV microbicideclinical trial implementationcost effectivedata managementdesignexperiencefollow-upimplementation processinstrumentmethod developmentmicrobicideparticipant safetypregnantprogramsprotocol developmentquality assurancesafety studysoundstatisticssymposiumtrial design
项目摘要
The Microbicide Trials Network (MTN) was on track to complete crucial studies assessing the safety of the
dapivirine vaginal ring in adolescents, pregnant women and breastfeeding women within the current project
period. Unfortunately, this work is being delayed as a result of the COVID-19 associated disruption of study
activities. To address these delays, the MTN Statistical and Data Management Center (MTN SDMC) is
requesting a one-year extension of funding (UM1AI068615) to support these critical clinical trials as well as
for the completion of the analyses of completed trials which have been interrupted due to the COVID-19
epidemic. Through this extension, the MTN SDMC will continue to support the development of a safe and
effective microbicide for HIV prevention by: 1. Ensuring the collection of complete, high quality data by
providing state-of-the-art secure data management systems and training according to best data and clinical
management practices. 2. Providing statistical and leadership and support throughout the protocol
development and implementation process, including study design, monitoring and analysis and reporting.
The MTN SDMC has extensive experience in the design, conduct and analysis of HIV prevention studies,
including studies of the dapivirine vaginal ring. The scientific leadership of the faculty engaged in the MTN
SDMC will ensure MTN trials are designed to obtain reliable answers to the most pressing questions in
microbicides development. Our systems for data collection, management, monitoring and analysis are all
well tested and in accordance with ICH guidelines. We will support the leadership group with timely and
accurate reporting of MTN studies throughout follow-up to study completion. We will continue to support the
MTN LC program through coordination of specimens and assay results, and with statistical analysis and
methods development. MTN SDMC statisticians will develop and deploy statistical methodologies to
increase the efficiency and rigor of the proposed program of microbicide trials.
杀微生物剂试验网络 (MTN) 有望完成评估杀微生物剂安全性的重要研究
当前项目中针对青少年、孕妇和哺乳期妇女的达匹韦林阴道环
时期。不幸的是,由于与 COVID-19 相关的研究中断,这项工作被推迟
活动。为了解决这些延迟问题,MTN 统计和数据管理中心 (MTN SDMC)
请求将资金延长一年(UM1AI068615)以支持这些关键的临床试验以及
用于完成因 COVID-19 中断的已完成试验的分析
流行性。通过此次延期,MTN SDMC 将继续支持安全、可靠的发展
通过以下方式有效预防艾滋病毒的杀菌剂: 1. 确保收集完整、高质量的数据
根据最佳数据和临床提供最先进的安全数据管理系统和培训
管理实践。 2. 在整个协议过程中提供统计、领导和支持
制定和实施过程,包括研究设计、监测、分析和报告。
MTN SDMC 在艾滋病毒预防研究的设计、实施和分析方面拥有丰富的经验,
包括达匹韦林阴道环的研究。从事 MTN 的教师的科学领导力
SDMC 将确保 MTN 试验的设计能够为最紧迫的问题获得可靠的答案
杀菌剂的开发。我们的数据收集、管理、监控和分析系统都是
经过充分测试并符合 ICH 指南。我们将及时、有力地支持领导班子
在研究完成的整个后续过程中准确报告 MTN 研究。我们将继续支持
MTN LC 程序通过协调样本和检测结果以及统计分析和
方法开发。 MTN SDMC 统计人员将开发和部署统计方法
提高拟议的杀菌剂试验计划的效率和严格性。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.
- DOI:10.1371/journal.pone.0080927
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Dimitrov D;Boily MC;Brown ER;Hallett TB
- 通讯作者:Hallett TB
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.
在第1阶段试验中,参与者的3个月与1个月的阴道降低了3个月与1个月阴道环的偏好。
- DOI:10.1089/jwh.2021.0121
- 发表时间:2022-07
- 期刊:
- 影响因子:3.5
- 作者:Roberts, Sarah T.;Hawley, Imogen;Luecke, Ellen;Mensch, Barbara;Wagner, Theresa;Hoesley, Craig;McClure, Tara;Islas, Clara P. Dominguez;Piper, Jeanna M.;Liu, Albert Y.;van der Straten, Ariane
- 通讯作者:van der Straten, Ariane
High incidence is not high exposure: what proportion of prevention trial participants are exposed to HIV?
- DOI:10.1371/journal.pone.0115528
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Dimitrov D;Donnell D;Brown ER
- 通讯作者:Brown ER
Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model.
使用贝叶斯分层复合泊松脆弱模型评估艾滋病毒预防试验的有效性。
- DOI:10.1002/sim.6884
- 发表时间:2016
- 期刊:
- 影响因子:2
- 作者:Coley,RebeccaYates;Brown,ElizabethR
- 通讯作者:Brown,ElizabethR
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.
- DOI:10.1097/qai.0000000000001160
- 发表时间:2016-12-15
- 期刊:
- 影响因子:0
- 作者:Hanscom B;Janes HE;Guarino PD;Huang Y;Brown ER;Chen YQ;Hammer SM;Gilbert PB;Donnell DJ
- 通讯作者:Donnell DJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Renata Brown其他文献
Elizabeth Renata Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Renata Brown', 18)}}的其他基金
The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base
CASCADE CLIMB:女性艾滋病毒感染者宫颈癌预防研究动员基地
- 批准号:
10543925 - 财政年份:2022
- 资助金额:
$ 347.1万 - 项目类别:
The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base
CASCADE CLIMB:女性艾滋病毒感染者宫颈癌预防研究动员基地
- 批准号:
10707161 - 财政年份:2022
- 资助金额:
$ 347.1万 - 项目类别:
CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center
HIV/AIDS数据协调中心的CVD和代谢并发症
- 批准号:
7931415 - 财政年份:2008
- 资助金额:
$ 347.1万 - 项目类别:
CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center
HIV/AIDS数据协调中心的CVD和代谢并发症
- 批准号:
7881416 - 财政年份:2008
- 资助金额:
$ 347.1万 - 项目类别:
CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center
HIV/AIDS数据协调中心的CVD和代谢并发症
- 批准号:
7691227 - 财政年份:2008
- 资助金额:
$ 347.1万 - 项目类别:
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
艾滋病毒/艾滋病临床试验网络的领导;
- 批准号:
8289674 - 财政年份:2006
- 资助金额:
$ 347.1万 - 项目类别:
Statistical and Data Management Center (SDMC): Microbicide Trials Network
统计和数据管理中心 (SDMC):杀菌剂试验网络
- 批准号:
9185920 - 财政年份:2006
- 资助金额:
$ 347.1万 - 项目类别:
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
艾滋病毒/艾滋病临床试验网络的领导;
- 批准号:
8109842 - 财政年份:2006
- 资助金额:
$ 347.1万 - 项目类别:
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
艾滋病毒/艾滋病临床试验网络的领导;
- 批准号:
8646020 - 财政年份:2006
- 资助金额:
$ 347.1万 - 项目类别:
Statistical and Data Management Center (SDMC): Microbicide Trials Network
统计和数据管理中心 (SDMC):杀菌剂试验网络
- 批准号:
8552185 - 财政年份:2006
- 资助金额:
$ 347.1万 - 项目类别:














{{item.name}}会员




